MRX Strangle Strategy
MRX (Marex Group plc Ordinary Shares), in the Financial Services sector, (Financial - Capital Markets industry), listed on NASDAQ.
Marex Group plc, a financial services platform provider company, provides liquidity, market access, and infrastructure services to clients in the energy, commodities, and financial markets in the United Kingdom, the United States, and internationally. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments. The company offers execution and clearing services in metals, agricultural products, energy and financial futures and options; liquidity and execution services for financial securities through trading desks that cover products, including foreign exchange, equities, fixed income, and others. It also operates as an agent to trade in OTC energy products using knowledge of the energy sector and relationships with clients for oil, power and gas, and shipping and freight products; and provides market-making services across commodities markets, such as metals, agricultural products, and energy markets. In addition, the company offers OTC traded hedging and customized OTC derivatives solutions; and risk management solutions across commodity markets comprising agriculture, metals, energy, and currency markets for trading houses, producers and consumers, and banks and distributors. Further, it engages in the structured notes business, which allows investors to build structured notes across asset classes, including commodities, equities, foreign exchange, and fixed-income products for private banks, independent asset managers, pension funds, and corporates.
MRX (Marex Group plc Ordinary Shares) trades in the Financial Services sector, specifically Financial - Capital Markets, with a market capitalization of approximately $4.19B, a trailing P/E of 13.49, a beta of 0.06 versus the broader market, a 52-week range of 27.91-58.49, average daily share volume of 1.1M, a public-listing history dating back to 1990, approximately 2K full-time employees. These structural characteristics shape how MRX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.06 indicates MRX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. MRX pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on MRX?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current MRX snapshot
As of May 15, 2026, spot at $56.40, ATM IV 40.90%, IV rank 16.99%, expected move 11.73%. The strangle on MRX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on MRX specifically: MRX IV at 40.90% is on the cheap side of its 1-year range, which favors premium-buying structures like a MRX strangle, with a market-implied 1-standard-deviation move of approximately 11.73% (roughly $6.61 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MRX expiries trade a higher absolute premium for lower per-day decay. Position sizing on MRX should anchor to the underlying notional of $56.40 per share and to the trader's directional view on MRX stock.
MRX strangle setup
The MRX strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MRX near $56.40, the first option leg uses a $59.22 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MRX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MRX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $59.22 | N/A |
| Buy 1 | Put | $53.58 | N/A |
MRX strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
MRX strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on MRX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on MRX
Strangles on MRX are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the MRX chain.
MRX thesis for this strangle
The market-implied 1-standard-deviation range for MRX extends from approximately $49.79 on the downside to $63.01 on the upside. A MRX long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current MRX IV rank near 16.99% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on MRX at 40.90%. As a Financial Services name, MRX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MRX-specific events.
MRX strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MRX positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MRX alongside the broader basket even when MRX-specific fundamentals are unchanged. Always rebuild the position from current MRX chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on MRX?
- A strangle on MRX is the strangle strategy applied to MRX (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With MRX stock trading near $56.40, the strikes shown on this page are snapped to the nearest listed MRX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MRX strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the MRX strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 40.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MRX strangle?
- The breakeven for the MRX strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MRX market-implied 1-standard-deviation expected move is approximately 11.73%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on MRX?
- Strangles on MRX are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the MRX chain.
- How does current MRX implied volatility affect this strangle?
- MRX ATM IV is at 40.90% with IV rank near 16.99%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.